Edgewell Personal Care Company
NYSE:EPCHousehold & Personal Products
+$1.26 today
- Market cap
- $1.30B
- Beta
- 0.49
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.67
- Dividend yield
- 2.52%
Volume 0.50M
Average 0.79M
EPC Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Edgewell Personal Care CompanyNYSE: EPC
Revenue · Q2 FY2026 · quarter ended Mar 2026
Revenue declines year over year
Q2 FY2026 revenue of $519.5M fell 10.5% year over year, behind the -5.3% change in trailing-twelve-month revenue. Sequentially, it rose 22.9% from the prior quarter. Over 3 fiscal years it compounded at +0.8% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 4 analysts of $1.99B (-10.4%) for the fiscal year ending Sep 2026, a slowdown from the -1.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $519.5M+22.9% QoQ
- Last fiscal yearSep 2025
- $2.22B-1.3% YoY
- LTMMar 2026
- $2.11B-5.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -10.5% | -8.3% | +2.2 pp |
| 1 year | -1.3% | -10.4% | -9.0 pp |
| 3-year CAGR | +0.8% | -2.4% | -3.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 2.22B USD
- Year-over-year change
- -1.3%
- 4-year CAGR
- +1.6%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 2.22B | -1.3% |
| FY2024 | 2024-09-30 | 2.25B | +0.1% |
| FY2023 | 2023-09-30 | 2.25B | +3.7% |
| FY2022 | 2022-09-30 | 2.17B | +4.0% |
| FY2021 | 2021-09-30 | 2.09B | — |
Revenue vs competitors
How EPC compares with its peers on the latest reported figures
- EPC's LTM Mar 2026 revenue of $2.11B is the 3rd highest of the 9 companies compared; the peer median is $1.44B.
- Its year-over-year change of -5.3% is the 7th highest of 9, against a peer median of +2.7%.
- Over three fiscal years its annual growth of +0.8% compares with a peer median of +2.0%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $5.13B | +3.7% | -1.1% | |
| LTM Jun 2026 | $2.87B | +0.8% | -3.6% | |
| LTM Mar 2026 | $2.11B | -5.3% | +0.8% | |
| LTM Mar 2026 | $1.66B | +5.1% | +3.2% | |
| LTM Mar 2026 | $1.45B | +2.3% | +0.7% | |
| LTM Mar 2026 | $1.44B | -14.2% | -12.6% | |
| LTM Mar 2026 | $1.34B | +3.1% | +6.9% | |
| LTM Apr 2026 | $1.25B | -10.5% | +10.0% | |
| LTM Mar 2026 | $1.16B | +5.1% | +5.0% | |
| Peer median (excluding EPC) | $1.44B | +2.7% | +2.0% | |
Competitors are the stored peer set for EPC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 2.09B | 2.17B | 2.25B | 2.25B | 2.22B |
| Cost of Revenue | 1.14B | 1.29B | 1.31B | 1.3B | 1.3B |
| Gross Profit | 951.2M | 880.5M | 940.8M | 955.7M | 924.9M |
| Gross Margin | 45.6% | 40.5% | 41.8% | 42.4% | 41.6% |
| Research & Development | 57.8M | 55.5M | 58.5M | 58.4M | 57.6M |
| Selling, General & Admin | 632.7M | 627.4M | 638.7M | 662.1M | 671.7M |
| Operating Expenses | 711.3M | 698.2M | 713.8M | 756.4M | 828.3M |
| Depreciation & Amortization | 87.1M | 89.9M | 91.4M | 88M | 88.8M |
| EBITDA | 302.1M | 285.4M | 317.6M | 285.4M | 185.6M |
| EBITDA Margin | 14.5% | 13.1% | 14.1% | 12.7% | 8.3% |
| Operating Income | 239.9M | 182.3M | 227M | 199.3M | 96.6M |
| Operating Margin | 11.5% | 8.4% | 10.1% | 8.8% | 4.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 67.9M | 71.4M | 78.5M | 76.5M | 73.2M |
| Other Income / Expenses | (92.8M) | (58.2M) | (79.3M) | (78.4M) | (73M) |
| Income Before Tax | 147.1M | 124.1M | 147.7M | 120.9M | 23.6M |
| Pre-Tax Margin | 7.0% | 5.7% | 6.6% | 5.4% | 1.1% |
| Income Tax Expense | 29.3M | 24.6M | 33M | 22.3M | (1.8M) |
| Net Income | 117.8M | 99.5M | 114.7M | 98.6M | 25.4M |
| Net Margin | 5.6% | 4.6% | 5.1% | 4.4% | 1.1% |
| EPS (Basic) | 2.15 | 1.87 | 2.24 | 1.98 | 0.53 |
| EPS (Diluted) | 2.12 | 1.86 | 2.21 | 1.97 | 0.53 |
| Weighted Avg Shares | 54.4M | 53.1M | 51.2M | 49.7M | 47.5M |
| Weighted Avg Shares (Diluted) | 55.2M | 53.6M | 51.8M | 50.1M | 47.6M |
Edgewell Personal Care Company
NYSE:EPC
Intrinsic Alpha fair value
Locked
Current Price
$28.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.